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ISF compared to the well controls. The CFS cases had signifi-
cantly higher scores on neuroticism, and significantly lower 
scores on extraversion than those with ISF or the well con-
trols. Personality features were correlated with selected 
composite characteristics of fatigue.   Conclusions:   Our re-
sults suggest that CFS is associated with an increased preva-
lence of maladaptive personality features and personality 
disorders. This might be associated with being noncompli-
ant with treatment suggestions, displaying unhealthy be-
havioral strategies and lacking a stable social environment. 
Since maladaptive personality is not specific to CFS, it might 
be associated with illness per se rather than with a specific 
condition.    Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Chronic fatigue syndrome (CFS) is an important pub-
lic health problem with unique diagnostic and man-
agement challenges. Studies using population-based ran-
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 Abstract 
  Background:   Chronic fatigue syndrome (CFS) presents 
unique diagnostic and management challenges. Personality 
may be a risk factor for CFS and may contribute to the main-
tenance of the illness.  Methods:  501 study participants were 
identified from the general population of Georgia: 113 peo-
ple with CFS, 264 with unexplained unwellness but not CFS 
(insufficient fatigue, ISF) and 124 well controls. We used the 
Personality Diagnostic Questionnaire, 4th edition, to evalu-
ate DSM-IV personality disorders. We used the NEO Five- 
Factor Inventory to assess personality features (neuroticism, 
extraversion, openness, agreeableness and conscientious-
ness). The Multidimensional Fatigue Inventory measured 5 
dimensions of fatigue, and the Medical Outcomes Survey 
Short Form 36 measured 8 dimensions of functional impair-
ment.   Results:   Twenty-nine percent of the CFS cases had at 
least 1 personality disorder, compared to 28% of the ISF cas-
es and 7% of the well controls. The prevalence of paranoid, 
schizoid, avoidant, obsessive-compulsive and depressive 
personality disorders were significantly higher in CFS and
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dom samples have estimated that CFS prevalence among 
adults ranges from 0.2 to 2.5%   [1–3]  . Most of the people 
affected have been ill for 5 years or longer, and a quarter 
are unemployed or receive disability benefits   [4]  . In spite 
of this morbidity, only 50% of those suffering from the 
illness have consulted a physician   [5]  . We have recently 
examined qualitative types of healthcare utilization bar-
riers and found 7 reoccurring barriers: attitudes, self-di-
agnosis, finances, time constraints, healthcare coverage, 
fear, and lack of trust and confidence in health profes-
sionals   [6]  . It might be suggested that these barriers are 
influenced by differential aspects of a person’s character, 
thoughts and feelings, i.e. his or her personality. A better 
understanding of how personality is related to CFS might 
improve our understanding of this illness and the care 
seeking behavior of individuals with the syndrome.
    The role of maladaptive personality as a risk factor for 
developing CFS, as a factor contributing to its morbidity, 
pursuit of and responsiveness to treatment, or as a conse-
quence of this chronic complex illness has been poorly 
explored. Published studies have reported around 40% of 
persons with CFS as having personality disorders, a rela-
tively high occurrence   [7–10]  . These studies considered 
personality on a categorical basis.
    However, it may be more productive to consider per-
sonality as a dimensional construct, with disorders re-
flecting extremes on a wide spectrum. The 5-factor mod-
el provides a structure of normal personality traits. These 
include: (1) neuroticism – the tendency to experience neg-
ative   affect  and  affective instability; (2) extraversion – a 
disposition toward energetic activity, sociability and pos-
itive affect; (3) openness to experience – an interest in
novel people, ideas and things, as well as intellectual and 
aesthetic tendencies; (4) agreeableness – the tendency to-
ward warmth, amiability and trust; and (5) conscientious-
ness – qualities such as diligence, goal orientation, fas-
tidiousness and dependability   [11]  . Previous studies have 
found higher scores of maladaptive personality traits in 
CFS patients compared to healthy controls   [12]  . In par-
ticular, studies have examined the relationship between 
fatigue and neuroticism, which may also be characterized 
by a tendency to display high emotional reactivity. Neu-
roticism has also been associated with negative health 
outcomes   [13]  . In general, a positive association between 
neuroticism and fatigue has been found  [14] , with CFS pa-
tients showing higher levels compared to healthy controls 
  [15]   and the general population   [16]  . These studies clearly 
highlight the important role of neuroticism in CFS. Other 
studies which have also examined other personality traits 
have yielded inconclusive results   [12] .
    Published studies evaluating personality associated 
with CFS have 2 major limitations. First, they enrolled 
CFS patients from primary or tertiary care centers. The 
potential effect of self-selection into medical care settings 
by higher (or lower) scores in neuroticism or any other 
dimension of personality could not be evaluated. Equally 
important, as noted in a recent review, associations be-
tween neuroticism and CFS likely reflect methodological 
issues such as differences in assessment instruments, pa-
tient selection criteria and CFS case definition, or the ab-
sence of an appropriate control group  [12]  . In the current 
study,   we   used   standardized    validated    instruments    to    
(1) describe the prevalence of personality disorders in a 
population-based sample of persons with and without
fatigue, (2) describe personality dimensions in persons 
with and without fatigue, and (3) relate dimensions of 
personality in CFS to illness-specific symptoms. We also 
used standardized and validated measures to define CFS, 
other unexplained fatiguing illness not meeting the cri-
teria for CFS (we term this ‘insufficient number of symp-
toms’ or ‘insufficient fatigue severity’, ISF), and well con-
trols.
  Methods 
  This study adhered to US Department of Health and Human 
Services human experimentation guidelines and received institu-
tional review board approval from the CDC (Centers for Disease 
Control and Prevention) and collaborating institutions. After a 
complete description of the study, all participants gave their writ-
ten informed consent. 
  Study  Design 
  Study participants were identified during a survey of unwell-
ness in metropolitan, urban and rural populations of Georgia, 
conducted between September 2004 and July 2005   [17]  . In brief, 
the study used random digit dialing to screen approximately 
3,000 metropolitan households, about 4,000 urban residences and 
about 5,000 residences in rural areas. Detailed telephone inter-
views were completed on 5,623 people aged 18–59 years, who were 
identified by a household informant as ‘well’, ‘unwell without fa-
tigue’ and ‘unwell with fatigue’, representing response rates of 56, 
67 and 71%, respectively. Based on their responses in the detailed 
telephone interviews, the subjects entering the 1-day clinical eval-
uation had been classified as (1) CFS-like, (2) chronically unwell, 
and (3) well. Of those who fit the criteria for the CFS-like group, 
469 volunteers were eligible for clinical evaluation based on a de-
tailed telephone interview, and 292 (62%) completed the clinical 
assessment. Of the eligible well, 481 were invited to participate, 
based on having matched the CFS-like subjects for age ( 8 3 years), 
sex, race/ethnicity and geographic stratum, and 223 (46%) com-
pleted the clinical assessment. Of those with chronic unwellness 
(having at least 1 of the 4 most common CFS-defining symp-
toms – fatigue, cognitive impairment, unrefreshing sleep, and  Nater   /Jones   /Lin   /Maloney   /Reeves   /Heim   
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muscle or joint pain – for   6  6 months), 505 people were random-
ly selected to participate, and 268 (53%) completed the clinical 
assessment. 
  C l i n i c a l   A s s e s s m e n t  
 During the clinical evaluation, we identified medical and psy-
chiatric exclusionary and comorbid conditions and classified the 
participants as CFS, ISF or well. A review committee of CDC and 
Emory University physicians and psychologists reviewed the 
medical history and clinical, laboratory and psychiatric evalua-
tions to determine the presence of medical and psychiatric condi-
tions.
    Psychiatric and Medical Conditions 
  To identify exclusionary psychiatric conditions as stipulated 
by the case definition   [18, 19]  , licensed and specifically trained 
psychiatric interviewers administered a semistructured inter-
view. To screen for medical conditions considered exclusionary 
for CFS, the participants completed past medical history ques-
tionnaires. A standardized physical examination was performed. 
Blood and urine specimens were obtained for laboratory screen-
ing tests to identify possible underlying or contributing medical 
conditions   [18, 19] .
  Measurement  of  Personality 
  Personality Diagnostic Questionnaire, 4th edition.  The Person-
ality Diagnostic Questionnaire, 4th edition (PDQ-4)   [20]  , is a 
100-item, self-administered, true/false questionnaire that yields 
personality diagnoses consistent with the DSM-IV diagnostic cri-
teria for axis II disorders. In the current study, the participants 
completed the instrument on a computer during their clinical 
evaluation. The PDQ-4 assesses the 10 personality disorders of 
the DSM-IV, and 2 additional personality disorders described in 
the appendix B of the DSM-IV  [21] . The PDQ total score provides 
an index of overall personality disturbance and is calculated by 
summing up all the pathological responses. A total score of   6 30 
indicates that the respondent likely has a personality disturbance. 
The PDQ-4 was designed for high sensitivity at the expense of low 
specificity. 
   NEO Five-Factor Inventory.   The NEO Five-Factor Inventory 
(NEO-FFI)   [11]   is a 60-item short form of the NEO Personality 
Inventory. The NEO-FFI assesses 5 personality domains: neurot-
icism, extraversion, openness to experience, agreeableness and 
conscientiousness. The reliability coefficients (Cronbach’s   ) that 
we found in our study for the 5 scales were the following: 0.89 
(neuroticism), 0.82 (extraversion), 0.72 (openness), 0.74 (agree-
ableness) and 0.82 (conscientiousness).
  Classification  of  Subjects 
  CFS is defined by (1) clinically unexplained (i.e. by other pri-
mary diagnoses that might explain fatigue), persistent or relaps-
ing fatigue of at least 6 months’ duration that is not the result of 
ongoing exertion, is not substantially alleviated by rest and results 
in a substantial reduction in previous levels of occupational, edu-
cational, social or personal activities, and (2) a concurrent occur-
rence of at least 4 accompanying symptoms (unusual postexer-
tional malaise, unrefreshing sleep, significant impairment of 
memory/concentration, headache, muscle pain, joint pain, sore 
throat and tender lymph nodes)   [18]  . As recommended by the in-
ternational CFS study group   [19]  , the study classified the partici-
pants as CFS, ISF (i.e. not meeting the criteria for CFS  [18] ) or well, 
using standardized instruments to measure symptoms and func-
tioning (i.e. the Multidimensional Fatigue Inventory to assess fa-
tigue status, the Medical Outcomes Survey Short Form 36 to mea-
sure functional impairment, and the CDC Symptom Inventory to 
evaluate the occurrence, frequency and severity of the 8 CFS-de-
fining symptoms). Cutoffs were used as in previous CDC popula-
tion-based studies of CFS   [1] .
  Statistical  Analyses 
  We used the Kolmogorov-Smirnov test to evaluate whether 
data were normally distributed. For metric data, group differenc-
es between CFS, ISF and well were calculated by general linear 
models. Homogeneity of variance was assessed using Levene’s 
test. For nonmetric data, differences between the 3 groups were 
analyzed using the Kruskal-Wallis analysis of variance. For mul-
tiple comparisons of means, Bonferroni-corrected results were 
used. Correlations between scores were computed using Spear-
man’s rho correlations. The analyses were two-tailed, with the 
level of significance set at p   !   0.05.
  R e s u l t s  
 Age, sex and race distributions were similar among the 
participants with CFS (mean age 44.3 years; 81.4% fe-
male; 74.3% white) and ISF (mean age 43.1 years; 76.1% 
female; 74.2% white), and the well controls (mean age 
44.5 years; 75.0% female; 76.6% white) (all comparisons 
were nonsignificant).
  At least 1 personality disorder was diagnosed in 33/113 
(29.2%) persons with CFS, 74/264 (28%) persons with ISF, 
and 9/124 (7.3%) well persons. The prevalence rates were 
significantly higher in the CFS and ISF groups compared 
to the well (  table 1  ).     This distribution was also reflected 
in the PDQ summary score, which was significantly dif-
ferent between the 3 groups, with the highest scores in the 
CFS group and the lowest in the well group (CFS: 23.29; 
ISF: 17.7; well: 9.3; F(2, 494) = 51.28; p   !   0.001; post hoc 
test: all comparisons p   !   0.001).
    The 3 groups differed significantly in their mean 
scores for several of the 5 NEO-FFI scales. The CFS group 
had the highest mean score for neuroticism, while the 
well group had the lowest mean score for neuroticism ( ta-
ble 2  ). Those with CFS had the lowest mean extraversion 
scores, and the well group had the highest mean scores. 
Well participants had significantly higher mean agree-
ableness and conscientiousness scores than the CFS or 
ISF groups, whereas the scores of the latter 2 groups were 
similar. The openness scale scores were similar for the 3 
diagnostic groups.
  Further, we were interested in whether the presence or 
absence of a personality disorder diagnosis resulted in   Personality Features and Disorders in 
Chronic Fatigue Syndrome 
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differential personality traits as measured by the NEO-
FFI. As   table 3   indicates, those with at least 1 personality 
disorder differed from those without personality disor-
ders with respect to mean scores for neuroticism and 
agreeableness scales, and there was a tendency toward 
significant differences for the other dimensions. 
    Finally, personality dimensions were associated with 
dimensions of fatigue (measured by the Multidimension-
al Fatigue Inventory) and functional impairment (mea-
sured by the Medical Outcomes Survey Short Form 36). 
Among the 5 personality dimensions, the strongest cor-
relations were found between neuroticism and both func-
tional impairment and fatigue in CFS and ISF. Correla-
tions of these factors with extraversion were similarly 
high, but the directions of the association were inverted 
(data not shown; the authors are happy to provide a full 
table of correlation coefficients upon request).
  Discussion 
  Categorically, 29% of our participants with CFS had a 
personality disorder, compared to 7% of the well controls. 
Our findings are reminiscent of previous studies which 
showed that almost 40% of CFS patients had at least 1 
personality disorder   [7, 8, 10]  . Interestingly, both our 
study and 2 of the earlier studies found obsessive-com-
pulsive personality disorder to be the most common per-
sonality disorder   [7, 8]  . One of the key features of obses-
sive-compulsive personality disorder is perfectionism, 
which has been shown to be markedly increased in pa-
tients with CFS   [22]  . Another study found that histrionic 
(23%) and borderline (17%) personality disorders were 
most common in CFS patients  [10] , and a study of chron-
ic fatigue showed that dependent (11%), histrionic (13%) 
and obsessive-compulsive (16%) personality disorders 
Table 1. P  DQ-4 personality disorder diagnoses in cases with CFS and ISF and in well controls
CFS ISF Well Statistics p
Paranoid PD 6/110 (5.5%) 13/263 (4.9%) 3/124 (2.4%) 2 (4) = 6.3 0.175
Schizoid PD 7/110 (6.4%) 9/263 (3.4%) 2/124 (1.6%) 2 (4) = 20.2 <0.001
Schizotypal PD 3/110 (2.7%) 5/263 (1.9%) 1/124 (0.8%) 2 (4) = 12.5 0.014 
Histrionic PD 3/110 (2.7%) 3/263 (1.1%) 0 2 (4) = 12.1 0.017
Narcissistic PD 4/110 (3.6%) 3/263 (1.1%) 0 2 (4) = 5.9 0.203
Borderline PD 2/110 (1.8%) 1/263 (0.4%) 0 2 (4) = 22.7 <0.001
Antisocial PD 0 0 0 N/A N/A
Avoidant PD 6/110 (5.5%) 13/263 (4.9%) 2/124 (1.6%) 2 (4) = 20.2 <0.001
Dependent PD 0 0 0 N/A N/A
Obsessive-compulsive PD 16/110 (14.5%) 34/263 (12.9%) 4/124 (3.2%) 2 (4) = 41.2 <0.001
Negativistic PD 3/110 (2.7%) 12/263 (4.6%) 0 2 (4) = 12.5 0.014
Depressive PD 7/110 (6.4%) 15/263 (5.7%) 0 2 (4) = 38.3 <0.001
PD = Personality disorder.
Table 2.   Distribution of summary NEO-FFI scores for personality dimensions in cases with CFS and ISF and in well controls
CFS (n = 113) ISF (n = 264) Well (n = 124) d.f. p
Neuroticism 1.98 (1.84–2.12) 1.67 (1.58–1.75) 0.92 (0.83–1.01) F(2, 495) = 84.01 <0.001a–c
Extraversion 2.04 (1.93–2.15) 2.24 (2.18–2.31) 2.66 (2.57–2.75) F(2, 497) = 41.34 <0.001b–d
Openness 2.27 (2.19–2.35) 2.19 (2.13–2.26) 2.29 (2.20–2.38) F(2, 496) = 1.87 0.155
Agreeableness 2.79 (2.71–2.88) 2.79 (2.74–2.84) 3.06 (3.00–3.13) F(2, 497) = 17.01 <0.001b, c
Conscientiousness 2.71 (2.61–2.81) 2.82 (2.76–2.88) 3.07 (2.99–3.15) F(2, 497) = 16.56 <0.001b, c
I  n the CFS, ISF and well columns, values in parentheses denote 95% CI. Post hoc tests, Bonferroni-corrected. a CFS versus ISF: p < 
0.001; b CFS versus well: p < 0.001; c ISF versus well: p < 0.001; d CFS versus ISF: p < 0.01. Nater   /Jones   /Lin   /Maloney   /Reeves   /Heim   
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were most common   [9]  . Interestingly, the occurrence of 
personality disorders in our study was substantially low-
er than in these other studies. We believe this is best ex-
plained by the fact that previously published studies en-
rolled participants from primary or tertiary care centers, 
whereas our study was population-based. Patients re-
cruited from primary or tertiary care centers may have 
more comorbid conditions than subjects recruited from 
the community. 
  Examining the dimensionality of personality features, 
we found increased neuroticism scores in CFS compared 
to the control group. Neuroticism is defined as a predis-
position to experience negative affect, i.e. anxiety and de-
pression. Persons with higher scores in neuroticism are 
more likely to be noncompliant with treatment sugges-
tions, display unhealthy behavioral strategies, lack a sta-
ble social environment and are therefore prone to illness. 
Neuroticism may also be characterized as a proneness to 
experience stress. It is interesting to see our results in the 
context of recent findings showing that high levels of per-
ceived stress are associated with the manifestation of CFS 
  [23, 24]  . As stressful experiences seem to play an impor-
tant role in triggering CFS symptoms, it might be argued 
that increased levels of neuroticism might mediate this 
relationship. Further, we found decreased extraversion 
scores in CFS. Energetic activity and sociability, the 2 key 
features of extraversion, may explain this finding. Clear-
ly, CFS is characterized by low levels of energy, and social 
interactions are down to a minimum. Also, decreased 
agreeableness and conscientiousness scores were found 
in CFS. Both personality traits might affect compliance 
with treatment regimes. Finally, no differences were 
found for openness.
    Our study differs from other studies in that it also in-
cluded a group of chronically fatigued participants who 
did not fulfill the criteria for a CFS diagnosis because they 
had an insufficient number of symptoms or insufficient 
fatigue severity (this group was termed ISF). Persons with 
ISF were very similar to those with CFS with respect to 
personality disorders and certain personality traits al-
though there were a few notable differences. However, 
current categorical approaches to the diagnosis of CFS 
might be complemented by a measurement of dimension-
al features in specific variables of interest. While subjects 
with ISF fared better than CFS cases with regard to their 
clinical features, the overall level of illness burden was 
significantly higher than in well persons. In this context, 
it is relevant to note that studies comparing CFS to other 
chronic illnesses, such as multiple sclerosis, did not find 
differences regarding the prevalence of comorbid person-
ality disorders   [9, 10]  . Personality disorders are therefore 
unlikely to be specific to CFS, but might be related to the 
chronicity and severity of an illness. Thus, our findings 
have an impact beyond the field of CFS research and 
should be considered in the context of chronic illness in 
general.
    The question arises whether personality dispositions 
are a premorbid risk factor, or whether they are a conse-
Table 3.   NEO-FFI dimensions in subjects with and without at least one personality disorder diagnosis in cases with CFS and ISF and 
in well controls
Prevalence of ≥1 PD CFS mean 
(33/113; 29.2%)
ISF mean 
(74/264; 28%)
Well mean 
(9/124; 7.3%)
d.f. p
N with PD 2.27 (2.03–2.52)  1.95 (1.80–2.11)  1.04 (0.85–1.23)  F(2, 113) = 12.14 <0.001a, b
N without PD 1.86 (1.70–2.02)** 1.55 (1.46–1.65)*** 0.91 (0.82–1.01)  F(2, 379) = 59.83 <0.001a–c
E with PD 1.94 (1.76–2.12) 2.13 (2.00–2.25) 2.30 (1.80–2.80) F(2, 113) = 2.04 0.135
E without PD 2.08 (1.95–2.22) 2.29 (2.21–2.37)* 2.69 (2.60–2.78)* F(2, 381) = 33.66 <0.001a–c
O with PD 2.18 (2.03–2.33) 2.16 (2.04–2.28) 2.02 (1.65–2.39) F(2, 112) = 0.4 0.668
O without PD 2.31 (2.21–2.41) 2.20 (2.13–2.28) 2.31 (2.21–2.40) F(2, 381) = 1.92 0.148 
A with PD 2.60 (2.41–2.80) 2.62 (2.51–2.72) 2.79 (2.38–3.21) F(2, 113) = 0.56 0.573
A without PD 2.87 (2.78–3.00)** 2.86 (2.80–2.92)*** 3.08 (3.01–3.15)* F(2, 381) = 11.36 <0.001b, d
C with PD 2.65 (2.45–2.84) 2.67 (2.53–2.81) 3.07 (2.67–3.47) F(2, 113) = 2.16 0.120
C without PD 2.74 (2.61–2.86) 2.88 (2.81–2.95)** 3.07 (2.99–3.15) F(2, 381) = 12.12 <0.001a, e
I  n the CFS, ISF and well columns, values in parentheses denote 95% CI. Post hoc tests, Bonferroni-corrected. PD = Personality 
disorder; N = neuroticism; E = extraversion; O = openness; A = agreeableness; C = conscientiousness. a CFS versus well: p < 0.001;
b ISF versus well: p < 0.001; c CFS versus ISF: p < 0.01; d CFS versus well: p < 0.01; e ISF versus well: p < 0.01. * p < 0.05, ** p < 0.01,
*** p < 0.001; independent t tests.  Personality Features and Disorders in 
Chronic Fatigue Syndrome 
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quence of the chronicity and severity of the illness known 
as CFS (and comorbid conditions), or both. While some 
authors have raised the possibility that personality alter-
ations are merely sequelae of the illness itself  [25] , a recent 
study in a population-based sample of twins found that 
emotional instability assessed 25 years earlier was predic-
tive of a later diagnosis of chronic fatigue   [23] .  Although 
that study did not evaluate CFS, its finding is still relevant 
for the understanding of the relationship between per-
sonality and CFS because its use of a prospective, longi-
tudinal design allows strong inferences to be made re-
garding the potentially causative contribution of person-
ality to the development of fatiguing illness. In contrast, 
a recent analysis using data from the British birth cohort 
study found that personality factors such as neuroticism 
and extraversion did not predict a diagnosis of CFS   [26] . 
It needs to be noted, though, that this study relied on self-
reported diagnoses of CFS. Finally, the question remains 
whether the severity of the illness might influence trait 
characteristics such as neuroticism. Feeling unwell might 
have an impact on how questions regarding personality 
and other psychological constructs are answered  [27, 28] . 
Our design did not allow controlling this possibility. We 
also measured depression and found that neuroticism 
was higher, and extraversion, openness, agreeableness 
and conscientiousness were lower in subjects with high 
depression scores (results not shown). The question of 
whether personality is primarily a predisposing factor for 
or a result of full-blown diagnostic CFS therefore still 
awaits empiric evaluation.
    Although we found that personality disorders and 
maladaptive personality features were relatively common 
in persons with CFS, more than 70% of our CFS sample 
did not fulfill the diagnosis for a personality disorder. 
Clearly, persons suffering from a comorbid personality 
disorder might need special attention when being treated. 
For example, cognitive behavioral therapy and graded 
  exercise therapy are widely held to be the most effective 
treatments for CFS although their results are inconsistent 
  [29]  . Such therapies require that patients understand, ad-
here to and practice specific activities to manage their 
thoughts and expenditure of physical energy. The mal-
adaptive personality features that we describe interfere 
with the ability to follow directions and maintain the self-
motivation needed for cognitive behavioral therapy and 
graded exercise therapy to be effective. Our findings sug-
gest that a successful treatment of persons with CFS may 
require special attention to address maladaptive person-
ality therapeutically. Further, maladaptive personality 
features might further the risk of negatively affecting the 
doctor-patient relationship by their interference with the 
patients’ motivation to attain by self-care a long-term ad-
aptation of their lifestyle and life goals. 
    Might those with certain personality disorders re-
spond differentially to different treatment regimes? Does 
the presence or absence of a personality disorder have 
implications for the prognosis or risk? How can this in-
formation be used for the treatment of CFS? Should a 
measurement of personality be included in a comprehen-
sive assessment of CFS   [30]  ? These are crucial questions 
that need to be addressed in future studies of personality 
and CFS. It is therefore important to consider our find-
ings when conceptualizing a treatment regime for indi-
viduals with CFS. Our results indicate high correlations 
between personality traits and illness domains. Similarly 
high associations were found in the well and ISF groups. 
This means that there is indeed a strong association be-
tween personality and the experience of symptoms and 
feelings of impairment; however, this is not specific to ill 
people. 
  Acknowledgments 
  This research was supported in part by an appointment to the 
Research Participation Program at the CDC administered by the 
Oak Ridge Institute for Science and Education via an interagency 
agreement between the US Department of Energy and the CDC 
(U.M.N.). The findings and conclusions in this report are those of 
the authors and do not necessarily represent the views of the fund-
ing agency. The authors acknowledge the expertise of Rebecca 
Devlin and Marjorie Morrissey from Abt Associates in conduct-
ing the study. The authors would also like to thank Dr. Hao Tian 
(CDC) for the internal validation of the personality disorder data. 
  Conflicts  of  Interest 
  Drs. Nater, Jones, Lin, Maloney and Reeves report no compet-
ing interests. Dr. Heim has received, or currently receives, grant 
funding from the National Institute of Mental Health, the Na-
tional Alliance for Research on Schizophrenia and Depression, 
the Anxiety Disorders Association of America, the Center for 
  Behavioral Neuroscience/SNF, the CDC, Eli Lilly and Novartis. 
She has received consulting fees from Bristol Myers Squibb and 
CeNeRx. She has received a contractor salary from CDC.  Nater   /Jones   /Lin   /Maloney   /Reeves   /Heim   
 
Psychother Psychosom 2010;79:312–318  318
 References 
   1  Reeves WC, Jones JF, Maloney E, Heim C, 
Hoaglin DC, Boneva RS, Morrissey M, Dev-
lin R: Prevalence of chronic fatigue syn-
drome in metropolitan, urban, and rural 
Georgia. Popul Health Metr 2007;    5:   5. 
    2  Reyes M, Nisenbaum R, Hoaglin DC, Unger 
ER, Emmons C, Randall B, Stewart JA, Ab-
bey S, Jones JF, Gantz N, Minden S, Reeves 
WC: Prevalence and incidence of chronic fa-
tigue syndrome in Wichita, Kansas. Arch In-
tern Med 2003;    163:   1530–1536. 
    3  Jason LA, Richman JA, Rademaker AW, Jor-
dan KM, Plioplys AV, Taylor RR, McCready 
W, Huang CF, Plioplys S: A community-
based study of chronic fatigue syndrome. 
Arch Intern Med 1999;    159:   2129–2137. 
   4  Reynolds KJ, Vernon SD, Bouchery E, Reeves 
WC: The economic impact of chronic fatigue 
syndrome. Cost Eff Resour Alloc 2004;    2:   4. 
    5  Solomon L, Reeves WC: Factors influencing 
the diagnosis of chronic fatigue syndrome. 
Arch Intern Med 2004;    164:   2241–2245. 
   6  Bracken RM, Linnane DM, Brooks S: Plasma 
catecholamine and nephrine responses to 
brief intermittent maximal intensity exer-
cise. Amino Acids 2009;    36:   209–217. 
   7  Ciccone DS, Busichio K, Vickroy M, Natel-
son BH: Psychiatric morbidity in the chronic 
fatigue syndrome: are patients with person-
ality disorder more physically impaired? J 
Psychosom Res 2003;    54:   445–452. 
    8  Henderson M, Tannock C: Objective assess-
ment of personality disorder in chronic fa-
tigue syndrome. J Psychosom Res 2004;    56:  
 251–254. 
   9  Pepper CM, Krupp LB, Friedberg F, Doscher 
C, Coyle PK: A comparison of neuropsychi-
atric characteristics in chronic fatigue syn-
drome, multiple sclerosis, and major depres-
sion. J Neuropsychiatry Clin Neurosci 1993;   
 5:   200–205. 
 10  Johnson SK, DeLuca J, Natelson BH: Person-
ality dimensions in the chronic fatigue syn-
drome: a comparison with multiple sclerosis 
and depression. J Psychiatr Res 1996;    30:   9–
20. 
  11  Costa PT Jr, McCrae RR: NEO PI-R profes-
sional manual. Odessa, Psychological As-
sessment Resources, Inc., 1992. 
  12 van Geelen SM, Sinnema G, Hermans HJ, 
Kuis W: Personality and chronic fatigue syn-
drome: methodological and conceptual is-
sues. Clin Psychol Rev 2007;    27:   885–903. 
 13  Appel     S,    Chapman   J,   Shoenfeld   Y:    Infec-
tion and vaccination in chronic fatigue 
  syndrome: myth or reality? Autoimmunity 
2007;    40:   48–53. 
  14  Magnusson AE, Nias DK, White PD: Is per-
fectionism associated with fatigue? J Psycho-
som Res 1996;    41:   377–383. 
  15 Buckley L, MacHale SM, Cavanagh JT, 
Sharpe M, Deary IJ, Lawrie SM: Personality 
dimensions in chronic fatigue syndrome and 
depression. J Psychosom Res 1999;    46:   395–
400. 
  16  Taillefer SS, Kirmayer LJ, Robbins JM, Lasry 
JC: Correlates of illness worry in chronic fa-
tigue syndrome. J Psychosom Res 2003;    54:  
 331–337. 
  17  Reeves WC, Wagner D, Nisenbaum R, Jones 
JF, Gurbaxani B, Solomon L, Papanicolaou 
DA, Unger ER, Vernon SD, Heim C: Chronic 
fatigue syndrome: a clinically empirical ap-
proach to its definition and study. BMC Med 
2005;    3:   19. 
  18  Fukuda K, Straus SE, Hickie I, Sharpe MC, 
Dobbins JG, Komaroff A: The chronic fa-
tigue syndrome: a comprehensive approach 
to its definition and study. International 
Chronic Fatigue Syndrome Study Group. 
Ann Intern Med 1994;    121:   953–959. 
  19  Reeves WC, Lloyd A, Vernon SD, Klimas N, 
Jason LA, Bleijenberg G, Evengard B, White 
PD, Nisenbaum R, Unger ER: Identification 
of ambiguities in the 1994 chronic fatigue 
syndrome research case definition and rec-
ommendations for resolution. BMC Health 
Serv Res 2003;    3:   25. 
  20  Hyler SE: Personality Diagnostic Question-
naire-4+ (PDQ-4+). New York, New York 
State Psychiatric Institute, 1994. 
 21  American Psychiatric Association: Diagnos-
tic and Statistical Manual of Mental Disor-
ders, ed 4, text rev (DSM-IV-TR). Wash-
ington, American Psychiatric Association, 
2000. 
 22  White C, Schweitzer R: The role of personal-
ity in the development and perpetuation of 
chronic fatigue syndrome. J Psychosom Res 
2000;    48:   515–524. 
  23  Kato K, Sullivan PF, Evengard B, Pedersen 
NL: Premorbid predictors of chronic fatigue. 
Arch Gen Psychiatry 2006;    63:   1267–1272. 
  24  Heim C, Wagner D, Maloney E, Papanico-
laou DA, Solomon L, Jones JF, Unger ER, 
Reeves WC: Early adverse experience and 
risk for chronic fatigue syndrome: results 
from a population-based study. Arch Gen 
Psychiatry 2006;    63:   1258–1266. 
  25 Christodoulou C, Deluca J, Johnson SK, 
Lange G, Gaudino EA, Natelson BH: Exami-
nation of Cloninger’s basic dimensions of 
personality in fatiguing illness: chronic fa-
tigue syndrome and multiple sclerosis. J Psy-
chosom Res 1999;    47:   597–607. 
  26  Harvey SB, Wadsworth M, Wessely S, Ho-
topf M: The relationship between prior psy-
chiatric disorder and chronic fatigue: evi-
dence from a national birth cohort study. 
Psychol Med 2008;    38:   933–940. 
  27  Bech P: Fifty years with the Hamilton scales 
for anxiety and depression: a tribute to Max 
Hamilton. Psychother Psychosom 2009;    78:  
 202–211. 
  28  Fava GA, Sonino N: Psychosomatic assess-
ment. Psychother Psychosom 2009;    78:   333–
341. 
 29  Rimes KA, Chalder T: Treatments for chron-
ic fatigue syndrome. Occup Med (Lond) 
2005;    55:   32–39. 
  30  Wise TN: Diagnostic criteria for psychoso-
matic research are necessary for DSM-V. 
Psychother Psychosom 2009;    78:   330–332.   